Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.
Nicole J. Horwood(University of East Anglia), Matthew T. Gillespie(Hudson Institute of Medical Research), Haruki Okamura(Mukogawa Women's University), T. Martin(The University of Melbourne), Jan Elliott(St George's Hospital), D Grail(Ludwig Cancer Research), M Kurimoto(Hayashibara (Japan)), Ashley R. Dunn(Ludwig Cancer Research), Nobuyuki Udagawa(Matsumoto Dental University)
Cited by 222
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
|Endocrinology|1988|945